July 23, 2021 12:41 PM | With information from .
15 minutes. The pharmaceutical company Pfizer announced this Friday that the United States (USA) bought another 200 million doses of its vaccine against COVID-19, which will be delivered between October of this year and April 2022.
This new order brings to 500 million the total doses of this product acquired so far by the US. The contract initially sealed with Pfizer provided for up to 600 million doses.
Separately, the two parties announced last month an agreement whereby the US will purchase another 500 million doses for countries with fewer resources.
“As a long-term partner of the US Government in the fight against this pandemic, we are proud of the impact of vaccination efforts in the country,” Albert Bourla, Pfizer’s president and CEO, said in a statement. Vaccines remain key to protecting lives from this devastating disease.
According to Pfizer, the new doses will help the US have broad access to vaccines until next year.
Pfizer and its German partner BioNTech, which was responsible for developing the vaccine, will deliver 110 million of these new doses before the end of the year and the other 90 million before April 30, 2022.
US and Pfizer contract
The contract gives the US the right to buy an updated version if it is developed and authorized to deal with the new variants.
The Pfizer / BioNTech vaccine is a major one in the American vaccination campaign. Its use is authorized for emergency purposes in the country for those over 12 years of age.
Vaccination in the country has registered a strong slowdown in recent weeks. For its part, infections have accelerated to the point of rising 53% in the last 7 days. In addition, hospital admissions for the disease increased 32%.